FDA Warning Letter — Damien Sanderlin, MD
The FDA took a Warning Letter action against Damien Sanderlin, MD on July 27, 2012 (Houston, TX). The action was issued by CBER and concerns biologics products. This facility has 2 recent FDA inspections on record.
Action Details
- Facility
- Damien Sanderlin, MD
- Date
- July 27, 2012
- Fiscal Year
- 2012
- Product Type
- Biologics
- Center
- CBER
- Location
- Houston, TX (United States)